{"version":"1.0","type":"link","title":"Real-World Outcomes and Subsequent Treatment Patterns in Patients with Advanced Non-Small Cell Lung Cancer and Atypical EGFR Mutations Receiving First-Line Osimertinib Monotherapy.","author_name":"Nieva JJ 외","author_url":"https://prs-insight.online/author/Nieva%20JJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96575","thumbnail_width":1200,"thumbnail_height":630}